Letter to the editor regarding “Alternative drugs for the treatment of gonococcal infections: old and new” <i>Expert Review of Anti-infective Therapy</i> . 2024. 22(9):753–759
Alison Luckey(Global Antibiotic Research & Development Partnership), Sarah M. McLeod(Innoviva (United States)), David Altarac(Entasis Therapeutics (United States))
Cited by 0
Related Papers
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
|Journal of Antimicrobial Chemotherapy|2019|123
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
|The Lancet Infectious Diseases|2024|98
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation
|European Journal of Clinical Pharmacology|2024|28